University of Michigan Apr 10 2025 Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new pandemic surged around them. By a year later, 66 million American adults had gotten at least one dose of a COVID-19 vaccine, at no cost to them. Now, a new study shows how wise that national investment in testing, buying and delivering the first vaccines was. In all, the national vaccine strategy more than paid for itself after just one year,

Tag-uri: Coronavirus